Category : Search result: pharmaceutical prices


Lobster Drops to $11 a Pound in Canada

Canadian consumers see lobster prices fall sharply to $11 per pound, offering rare relief as overall food costs climbed 4.2% last month. Discover the factors behind this seasonal drop.

Gas Prices Fall Again Across the Maritimes

Drivers in the Maritimes are seeing relief at the pumps as fuel prices drop. Get the latest details on this welcome trend and what it means for your wallet.

Fox Host Debunks Trump's 600% Drug Price Cut Claim

A Fox News anchor delivered a brutal math lesson on air, highlighting the impossibility of Trump's claim about slashing prescription drug prices by 600%. See the reality vs. perception clash unfold.

Health Canada Approves Drug for Rare Disease

Health Canada has granted approval for a new pharmaceutical treatment targeting a rare disease, offering hope for patients. Learn about the regulatory decision and its impact.

Pfizer 2026 profit forecast below expectations

Pfizer projects 2026 profits below Wall Street estimates due to a steep drop in COVID product sales and loss of exclusivity for key drugs. Get the full business analysis.

N.B. Fuel Prices Drop 7.9 Cents After EUB Weekend Change

New Brunswick drivers got a break at the pumps as the Energy and Utilities Board made a surprise weekend adjustment, lowering gasoline prices by 7.9 cents per litre. Get the details on this significant price drop.

Canadian Coffee Prices Surge in December 2025

Canadian consumers are facing steeper coffee bills this holiday season. A new report confirms rising costs are real, not imagined. Discover the factors behind the price hike.

China's Biopharma Surge Challenges Global Drug Leaders

China's biopharma industry is accelerating, fueled by record investment and streamlined supply chains. With faster development times and massive deals like AstraZeneca's $5.2B pact, the global drug innovation race is heating up. Discover the shift from ou

Eli Lilly cuts price of obesity drug Zepbound

Pharmaceutical giant Eli Lilly has reduced the price of its obesity medication Zepbound to improve patient access. The move comes amid growing demand for GLP-1 drugs in Canada and globally.

Grey Bruce drug disposal nets meds for hockey tickets

Grey Bruce residents exchanged unused pharmaceuticals for Barrie Colts hockey tickets in a successful medication safety initiative. Learn how this program helps combat opioid misuse and environmental contamination.

Dipharma's Novel Method Detects Nitrosamine Risks

Dipharma publishes a peer-reviewed study unveiling a novel method to detect and characterize nitrosamine impurities in Active Pharmaceutical Ingredients, enhancing drug safety and regulatory compliance.

Novo Nordisk Alzheimer's Drug Trials Fail

Danish pharmaceutical giant Novo Nordisk faces major setback as Alzheimer's drug trials fail. Learn how this impacts the weight-loss leader's expansion plans.

Eli Lilly Reaches $1 Trillion Valuation Milestone

Eli Lilly becomes the first pharmaceutical company to achieve a US$1 trillion market valuation, driven by unprecedented demand for its weight-loss treatments. Discover how this milestone reshapes the industry.

Denmark compensates for Novo Nordisk vision loss

Danish authorities provide compensation to patients experiencing vision loss linked to Novo Nordisk medications. Learn about the pharmaceutical safety developments affecting Canadian consumers.

LCBO delays price hikes after industry revolt

The LCBO has delayed major pricing changes until April 1 after facing widespread industry backlash. The move follows pressure from bars, restaurants, and retailers across Ontario.

J&J buys Halda Therapeutics for $3.05 billion

Johnson & Johnson expands its oncology portfolio with $3.05 billion acquisition of Halda Therapeutics, strengthening its cancer treatment pipeline. Learn about this major healthcare investment.

Canadian inflation cools to 2.2% in October

Canada's inflation rate dropped to 2.2% in October as gas and grocery prices declined. Explore provincial breakdowns and economic implications for Canadian households.

Page 1 of 4